A Multicenter, Double-Blind, Randomized Study of the Safety and Efficacy of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-Naive Adults.
Phase of Trial: Phase II
Latest Information Update: 27 May 2014
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Therapeutic Use
- 27 May 2014 New trial record